Arrow
Fòs Feminista | International Alliance for Sexual and Reproductive Health, Rights, and Justice
YEAR 2022

Domain Score Overview

The U.S. government, including the White House, Congress, and relevant federal agencies, should engage in global health assistance in the domains of HIV and AIDS, Maternal and Child Health, and Family Planning in ways that promote sexual and reproductive health and rights (SRHR) around the world. Data and documentation supporting these actions should be reasonably accessible to the public.

C

This is an average of the actor scores.

Family Planning

The U.S. Government received a 73 (C) with transparency and a 77 (C+) without transparency for the Family Planning (FP) domain across all actors in 2022. Global FP efforts were not meaningfully included in most whole-of-government actions or key agency-level actions for both the Department of State and United States Agency for International Development (USAID) in 2022. This omission reinforced the siloed nature of global health programs and did not support the implementation of integrated sexual and reproductive health (SRH) programming based in evidence and human rights. Most agency-level actions were gender accommodating as they reinforced a gender binary and did not use inclusive language such as “internal and external condoms.” An inadequate funding request from the White House, a low level of appropriated funding by the U.S. Congress for global FP programs, and the disbursement of FP funds by USAID that was not responsive to need affected the low grade in this domain. Actors received low to moderate transparency scores for actions graded in the FP domain which also impacted the overall score for 2022.

C+
White House
C+
Congress
F
Department of State
C
US Agency for International Development
NA
Department of Health and Human Services
NA
Department of Defense
C+

This is an average of the actor scores.

Maternal and Child Health

The U.S. Government received a 79 (C+) with transparency and an 83 (B) without transparency for the Maternal and Child Health (MCH) domain across all actors in 2022. Though global MCH efforts were meaningfully included in the National Strategy on Gender Equity and Equality, MCH was omitted from some whole-of-government actions as well as key agency-level actions from both the Department of State and the United States Agency for International Development (USAID). This omission reinforced the siloed nature of global health programs and did not support the implementation of integrated programming based in evidence and human rights. In most instances, agency-level actions were gender accommodating as they reinforced a gender binary and did not use inclusive language such as “pregnant and breastfeeding persons,” which excluded the experiences of all people who can become pregnant. All actors received low to moderate transparency scores for actions graded in the MCH domain. The continued lack of funding information for the Department of Health and Human Services (HHS) global MCH efforts and low scores for appropriate use of funds by USAID and the Department of State also negatively affected the overall MCH domain grade in 2022.

B+
White House
A
Congress
F
Department of State
C
US Agency for International Development
D-
Department of Health and Human Services
NA
Department of Defense
B+

This is an average of the actor scores.

HIV & AIDS

The U.S. Government (USG) received an 89 (B+) with transparency and a 94 (A-) without transparency in the HIV and AIDS domain across all actors in 2022. This grade reflected the continued commitment of the USG to support the President’s Emergency Plan for AIDS Relief (PEPFAR) to implement programs that were based in evidence, consistent with international human rights norms, and responsive to need. However, the majority of PEPFAR actions graded across actors in 2020 were gender accommodating and not gender transformative. All actors received low or moderate transparency scores for actions graded in the HIV and AIDS domain. Budget scores were relatively high across actors where budget data were available, and transparency of funding information was high for all actors except the Department of Defense (DoD). For the first time, funding information was available for the Department of Health and Human Services (HHS), which had a positive impact on overall scores. Consistent with previous years, the domain grade for HIV and AIDS was higher than the Maternal and Child Health and Family Planning domains across actors in 2022.

A-
White House
A
Congress
A-
Department of State
B+
US Agency for International Development
C+
Department of Health and Human Services
D
Department of Defense

B-

Overall SRHR Score

The U.S. Government received an 81 (B-) with transparency and an 84 (B) without transparency for sexual and reproductive health and rights (SRHR) overall in 2022. The overall SRHR grade was increased by several White House actions that explicitly promoted SRHR globally, including the Executive Order on Protecting Access to Reproductive Healthcare Services and the United States Strategy to Combat Gender Based Violence Globally. Following the overturn of Roe v. Wade, the Executive Order included an affirmative statement from the White House that confirmed the Biden administration’s commitment to supporting SRHR domestically and globally. However, global MCH and FP efforts were not meaningfully included in several whole-of-government and agency-level actions for the Department of State and United States Agency for International Development (USAID), which did not support the implementation of integrated U.S. global health programs that promote SRHR. Additionally, the overall SRHR grade was negatively impacted by low or inadequate funding determinations in the FP domain across actors, a lack of gender transformative elements across actions, low transparency of actions for all actors except Congress in the HIV and AIDS domain, and the incomplete funding data for the Department of Health and Human Services (HHS) and Department of Defense (DoD) in 2022.